Mr Soriot has been a Director of CSL Limited since August 2020.Skills and experience:
Mr Soriot has non-executive experience in the clincial-stage biotechnology sector. Mr Soriot brings a passion for science and medicine as well as significant experience in established and emerging markets, strength of strategic thinking, a successful track record of managing change and executing strategy, and the ability to lead a diverse organisation.
Mr Soriot is the Chief Executive Officer of AstraZeneca, and has held this position since 2012. Before this he served as Chief Operating Officer of Roche’s pharmaceuticals division from 2010 to September 2012 and, prior to that, Chief Executive Officer of Genentech, a biologics business, where he led its successful merger with Roche.
Mr Soriot joined the pharmaceutical industry in 1986 and has worked in senior management roles in numerous major companies around the world.Other directorships and offices (current and recent):
- Chief Executive Officer of AstraZeneca (since October 2012); and
- Former Director of Viela Bio, Inc (from October 2019 to August 2020).
Board Committee membership:
- Member of the Innovation and Development Committee